Specialty Pharmaceuticals
Total Trials
7
As Lead Sponsor
As Collaborator
0
Total Enrollment
491
NCT03154333
Safety and Efficacy of Diacerein 1% Ointment for Subjects With Epidermolysis Bullosa Simplex (EBS)
Phase: Phase 2
Role: Lead Sponsor
Start: Jun 1, 2017
Completion: Oct 31, 2018
NCT03389308
Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex
Start: Dec 1, 2017
Completion: Apr 17, 2020
NCT03473184
A 4-Day Study to Evaluate the Photoxicity of Diacerein 1% Topical Ointment in Healthy Volunteers
Phase: Phase 1
Start: Dec 12, 2017
Completion: Dec 15, 2017
NCT03473197
A 6-Week Study to Evaluate the Photoallergic Potential of Diacerein 1% Ointment in Healthy Volunteers
Start: Jan 8, 2018
Completion: Mar 9, 2018
NCT03472534
A 21 Day Irritation Study in Healthy Volunteers With Diacerein 1% Ointment
Start: Jan 9, 2018
Completion: Jan 30, 2018
NCT03472547
A Study of Sensitizing Potential of Diacerein 1% Ointment in Healthy Subjects
Start: Jan 15, 2018
Completion: Mar 3, 2018
NCT03472287
To Evaluate the Pharmacokinetic of Diacerein and Rhein After Maximum Use in Patients With Epidermolysis Bullosa (EB)
Start: May 18, 2018
Completion: Feb 14, 2019
Loading map...